213 AZACITIDINE (AZA) IN HIGHER RISK MDS PATIENTS WITH CHROMOSOME 7 ABNORMALITIES (ABN 7): RESULTS OF A RETROSPECTIVE STUDY FROM THE GFM AND GESMD REGISTRIES.

Authors :: Campelo, M. Díez
Lorenzo, J.I.
Itzykson, R.
Rojas, S.M.
Berthon, C.
Luño, E.
Beyne-Rauzy, O.
Pérez-Oteyza, J.
Vey, N.
Bargay, J.
Park, S.
Cedena, T.
Bordessoule, D.
Muñoz, J.A.
Gyan, E.
Such, E.
Visanica, S.
Benlloch, L.
de Botton, S.
Hernández-Rivas, J.M.
Source :: Leukemia Research. Apr2015 Supplement 1, Vol. 39, pS107-S107. 1p.
Publication Year :: 2015

Subjects :: *MYELODYSPLASTIC syndromes
*5Q deletion syndrome
*PRELEUKEMIA
*LEUKEMIA
*LEUKEMIA treatment
*LEUKEMIA diagnosis
*MEDICAL care

Full Text Access

Tools